Zichlin, Miriam L.
Mu, Fan
Leo, Sam
Ayyagari, Rajeev
Funding for this research was provided by:
Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel
Article History
Accepted: 6 July 2021
First Online: 4 September 2021
Declarations
:
: This study was funded by Teva Pharmaceutical Industries Ltd, Petach Tikva, Israel.
: Miriam L. Zichlin, Fau Mu, and Rajeev Ayyagari are employees of Analysis Group, Inc. Sam Leo is an employee of Teva Pharmaceuticals.
: This study received an exemption from the New England Institutional Review Board.
: Not applicable.
: Not applicable.
: These data are not publicly available.
: Not applicable.
: Miriam L. Zichlin, Fan Mu, and Rajeev Ayyagari contributed to the conception and design of the study, analysis and interpretation of the data, and drafting of the manuscript. Sam Leo contributed to the conception and design of the study, interpretation of the data, and drafting of the manuscript. All authors met the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.